FDA’s Drug Labeling Decisions Complicated By Uncertain Target Audience, Limited Authority
Executive Summary
Do drug labels try to serve too many masters? With no clear agreement on drug labels’ end user and FDA’s incomplete control of label content, the agency and its Pharmaceutical Science Advisory Committee struggle over how to convey drug-drug interaction information in labeling.